摘要 |
<p>Medicinal compositions, which contain blood coagulation factor VIII and/or von Willebrand factor in an amount effective in hemostatis, for preventing and treating hemorrhagic diseases associating thrombopathy induced not by blood coagulation factor failures or von Willebrand factor failures but by a decrease in circulatory platelet count or abnormality in platelet function; and a method of treating hemorrhagic diseases which comprises administering blood coagulation factor VIII and/or von Willebrand factor in an amount effective in hemostatis to patients with the hemorrhagic diseases associating thrombopathy.</p> |